Abstract 702
Background
Cancer-directed surgery is the principal therapy for solid tumors. One-month mortality after surgery remains an important criterion for evaluating the quality of surgical treatment. Socioeconomic factors play important roles in the modern biopsychosocial medical model. Here we studied the relationship between socioeconomic factors and one-month mortality after surgery in 17 primary solid tumors.
Methods
Based on the Surveillance, Epidemiology, and End Results database between 2004 and 2014, we focused on the socioeconomic factors, containing ethnicity, marital status, insurance status, household income, educational level, residence, unemployment level, and poverty level. The top 17 common cancer sites were selected, including bladder, breast, cervix, colorectum, esophagus, kidney, liver, lung, melanoma, oral cavity, ovary, pancreas, small intestine, stomach, testis, thyroid, uterine. The primary outcome was that patients died within one month after surgery. The control group was patients surviving beyond one month. We performed multivariable logistic regression model and subgroup analysis to detect the association.
Results
There were 24,233 (1.6%) patients dying within one month after surgery among 1,550,375 persons with primary solid cancers. Adjusted by age, gender and stage, patients with a unmarried state (aOR [adjusted odds ratio] 1.550, 95% CI [confidence interval] 1.504-1.597), Medicaid/uninsured (aOR 1.563, 95% CI 1.491-1.639), a low-income level (aOR 1.100, 95% CI 1.044-1.158), a low educational level (aOR 1.107, 95% CI 1.061-1.155), or a high poverty level (aOR 1.089, 95% CI 1.041-1.140), had significantly high risks of one-month mortality (All p values < 0.001). No significant association was found as for ethnicity, residence or unemployment. In the subgroup analysis by different cancer sites, it was found that the effects of the above-mentioned factors on mortality were almost consistent with overall.
Conclusions
Socioeconomically disadvantaged people tend to have high risks of one-month mortality after cancer-directed surgery. Especially in patients with unmarried or Medicaid/uninsured status, the risks were much higher than other factors.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Wei Sun.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2162 - Clinical Benefit and Prices of Cancer Drugs in the US and Europe
Presenter: Kerstin Vokinger
Session: Poster Discussion - Public policy
Resources:
Abstract
4743 - Determinants of the Cancer Drug Funding Process in Canada
Presenter: Joanna Gotfrit
Session: Poster Discussion - Public policy
Resources:
Abstract
6081 - Biosimilar Substitution: European Prescriber Perspectives
Presenter: Michael Reilly
Session: Poster Discussion - Public policy
Resources:
Abstract
1218 - Cost avoided in drugs derived from participation in clinical trials in colorectal cancer
Presenter: Luis Sánchez- Rubio Ferrández
Session: Poster Discussion - Public policy
Resources:
Abstract
3453 - Accessibility and Affordability to Trastuzumab for Breast cancer patients: voices of the Global Oncology community from ONCOLLEGE 001 survey – part 2
Presenter: Sara Altuna
Session: Poster Discussion - Public policy
Resources:
Abstract
3302 - Poster Discussion - Public policy - Analysis of 105.000 cancer patients; have they been discussed in oncologic multidisciplinary team meetings? A nationwide population-based study in the Netherlands
Presenter: Janneke Walraven
Session: Poster Discussion - Public policy
Resources:
Abstract
5246 - Reaching sustainable oncology care via the National Cancer Control Program (NCCP)
Presenter: Branko Zakotnik
Session: Poster Discussion - Public policy
Resources:
Abstract
5586 - Changing landscape of clinical cancer trials in Germany
Presenter: Susen Burock
Session: Poster Discussion - Public policy
Resources:
Abstract
5192 - Comparison between phase III randomized clinical trials and their preceeding phase II studies.
Presenter: Ivan Lyra-Gonzalez
Session: Poster Discussion - Public policy
Resources:
Abstract
5811 - Projecting overall survival data for health-economic models in oncology: do maturity levels impact uncertainty?
Presenter: Isabelle Borget
Session: Poster Discussion - Public policy
Resources:
Abstract